Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-6,059
Closed -$686K 31
2022
Q4
$686K Sell
6,059
-4,616
-43% -$507K 0.42% 26
2022
Q3
$860K Sell
10,675
-613
-5% -$51.9K 0.33% 44
2022
Q2
$841K Hold
11,288
0.29% 59
2022
Q1
$1.44M Hold
11,288
0.45% 43
2021
Q4
$1.51M Sell
11,288
-784
-6% -$113K 0.4% 60
2021
Q3
$1.65M Hold
12,072
0.45% 45
2021
Q2
$1.29M Hold
12,072
0.36% 63
2021
Q1
$1.08M Hold
12,072
0.33% 83
2020
Q4
$1.12M Hold
12,072
0.35% 81
2020
Q3
$1.24M Sell
12,072
-968
-7% -$101K 0.46% 47
2020
Q2
$1.32M Buy
13,040
+3,292
+34% +$294K 0.52% 43
2020
Q1
$656K Buy
+9,748
New +$607K 0.28% 56

Other funds holding DXCM

CNA Financial's DXCM Position: Q1 2023 in Review

CNA Financial sold out of DexCom (DXCM) in Q1 2023, closing a stake of 6,059 shares — an estimated $686K sold.

CNA Financial first reported a position in DXCM in Q1 2020 and held it in 12 quarters. The position peaked at $1.65M in Q3 2021. 904 funds tracked by Wall St. Rank hold DXCM as of Q1 2023.

  • CNA Financial reported no remaining DexCom position as of Q1 2023 after selling out during the quarter.
  • CNA Financial sold 6,059 DexCom shares in Q1 2023, an estimated $686K.
  • CNA Financial first reported a position in DexCom in Q1 2020 and held it in 12 quarters.
  • CNA Financial's DexCom position peaked at $1.65M in Q3 2021.
  • 904 funds tracked by Wall St. Rank held DexCom as of Q1 2023.

Based on CNA Financial's 13F filing for Q1 2023, filed 11 May 2023.